Co-mutagenicity of coumarin (1,2-benzopyrone) with aflatoxin B1 and human liver S9 in mammalian cells

Food and Chemical Toxicology

Volumn 37, Issue 6, 1999, Pages 581-589

  Goeger, D E ^a   Hsie, A W ^a   Anderson, K E ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Aftatoxin B1; CHO HPRT mutation assay; Coumarin; Liver S9

Indexed keywords

AFLATOXIN B1; COUMARIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; NIFEDIPINE;

ANIMAL CELL; ARTICLE; CHEMICAL MODIFICATION; CHO CELL; CHROMOSOME ABERRATION; CYTOTOXICITY; DRUG METABOLISM; GENOTOXICITY; HAMSTER; HUMAN; HUMAN CELL; LIVER CELL; MUTAGENICITY; NONHUMAN; SISTER CHROMATID EXCHANGE;

AFLATOXIN B1; ANIMALS; BIOTRANSFORMATION; CELLS, CULTURED; CHO CELLS; COUMARINS; CRICETINAE; DRUG SYNERGISM; HUMANS; LIVER; MUTAGENICITY TESTS; MUTAGENS;

CRICETINAE; CRICETULUS GRISEUS; MAMMALIA; RODENTIA;

EID: 0032861823     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(99)00046-0     Document Type: Article

References (72)

1. Ames B.N., McCann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutation Research. 31:1975;347-364.
2. 1. Proceedings of the National Academy of Sciences of the U.S.A. 87:1990;4790-4793.
3. Born S.L., Rodriguez P.A., Eddy C.L., Lehman-McKeeman L.D. Synthesis and reactivity of coumarin 3,4-epoxide. Drug Metabolism and Disposition. 25:1997;1318-1323.
4. 1 metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Research. 41:1981;67-72.
5. 1 to mutagens by human liver. Biochemical and Biophysical Research Communications. 82:1978;348-355.
6. Burke M.D., Thompson S., Weaver R.J., Wolf C.R., Mayer R.T. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochemical Pharmacology. 48:1994;923-936.
7. Carlton B.D., Aubrun J-C., Simon G.S. Effects of coumarin following perinatal and chronic exposure in Sprague-Dawley rats and CD-1 mice. Fundamental and Applied Toxicology. 30:1996;145-151.
8. Casley-Smith J.R., Morgan R.G., Piller N.B. Treatment of lymphedema of the arms and legs with 5,6-benzo-[a]-pyrone. New England Journal of Medicine. 329:1993;1158-1163.
9. Cohen A.J. Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man. Food and Cosmetics Toxicology. 17:1979;277-289.
10. Cox D., O'Kennedy R., Thornes R.D. The rarity of liver toxicity in patients treated with coumarin (1,2-benzopyrone). Human Toxicology. 8:1989;501-506.
11. 1 and comparison to CYP1A2 and CYP2A3. Carcinogenesis. 12:1991;355-359.
12. 1 biotransformation in rabbit pulmonary and hepatic microsomes. Toxicology. 74:1992;19-32.
13. De Long M.J., Prochaska H.J., Talalay P. Induction of NAD(P)H:quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: a model system for the study of anticarcinogens. Proceedings of the National Academy of Sciences of the U.S.A. 83:1986;787-791.
14. 1-epoxide. Carcinogenesis. 2:1981;299-306.
15. Dominguez K., Fentem J.H., Garle M.J., Fry J.R. Comparison of Mongolian gerbil and rat hepatic microsomal monooxygenase activities: high coumarin 7-hydroxylase activity in the gerbil. Biochemical Pharmacology. 39:1990;1629-1631.
16. Estabrook R.W., Peterson J., Baron J., Hildebrandt A. The spectrophotometric measurement of turbid suspensions of cytochromes associated with drug metabolism. Methods in Pharmacology. 2:1972;303-350.
17. Evans J.G., Gaunt I.F., Lake B.G. Two-year toxicity study on coumarin in the baboon. Food and Cosmetics Toxicology. 17:1979;187-193.
18. Faurschou P. Toxic hepatitis due to benzo-pyrone. Human Toxicology. 1:1982;149-150.
19. Fentem J.H., Fry J.R. Metabolism of coumarin by rat, gerbil and human liver microsomes. Xenobiotica. 22:1992;357-367.
20. Fentem J.H., Fry J.R., Thomas N.W. Species differences in the hepatotoxicity of coumarin: A comparison of rat and Mongolian gerbil. Toxicology. 71:1992;129-136.
21. Fentem J.H., Fry J.R., Whiting D.A. o-Hydroxyphenylacetaldehyde: A major novel metabolite of coumarin formed by rat, gerbil and human liver microsomes. Biochemical and Biophysical Research Communications. 179:1991;197-203.
22. Fernandez-Salguero P., Hoffman S.M. G., Cholerton S., Hohrenweiser H., Raunio H., Rautio A., Pelkonen O., Huang J-d., Evans W.E., Idle J.R., Gonzalez F.J. A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. American Journal of Human Genetics. 57:1995;651-660.
23. Feuer G., Kellen J.A., Kovacs K. Suppression of 7,12-dimethylbenz(a)anthracene-induced breast carcinoma by coumarin in the rat. Oncology. 33:1976;35-39.
24. 1 metabolism in human liver. Proceedings of the National Academy of Sciences of the U.S.A. 87:1990;8306-8310.
25. 1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicology and Applied Pharmacology. 141:1996;595-606.
26. 1. Cancer Research. 54:1994;101-108.
27. Galloway S.M., Armstrong M.J., Reuben C., Colman S., Brown B., Cannon C., Bloom A.D., Nakamura F., Ahmed M., Duk S., Rimpo J., Margolin B.H., Resnick M.A., Anderson B., Zeiger E. Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: Evaluation of 108 chemicals. Environmental and Molecular Mutagenesis. 10:(Suppl. 10):1987;1-175.
28. Gangolli S.D., Shilling W.H., Grasso P., Gaunt I.F. Studies on the metabolism and hepatotoxicity of coumarin in the baboon. Biochemical Society Transactions. 2:1974;310-312.
29. Goeger D.E., Anderson K.E. Coumarin-induced changes in δ-aminolevulinic acid synthase and cytochrome P-450 in the chick embryo liver. Food and Chemical Toxicology. 29:1991;145-151.
30. Goeger D.E., Anderson K.E. Biochemical characterization of coumarin 7-hydroxylase activity in chick embryo liver microsomes. Biochemical Pharmacology. 43:1992;363-369.
31. 1-induced gene mutation in a mammalian cell system: a species difference in mutagen activation and protection with chick embryo and rat liver S9. Environmental and Molecular Mutagenesis. 32:1998;64-74.
32. Grigg G.W. Genetic effects of coumarins. Mutation Research. 47:1977/1978;161-181.
33. 1 and relevance to risk of human liver cancer. Environmental Health Perspectives. 104:(Suppl. 3):1996;557-562.
34. Guengerich F.P., Martin M.V., Beaune P.H., Kremers P., Wolff T., Waxman D.J. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. Journal of Biological Chemistry. 261:1986;5051-5060.
35. Hagan E.C., Hansen W.H., Fitzhugh O.G., Jenner P.M., Jones W.I., Taylor J.M., Long E.L., Nelson A.A., Brouwer J.B. Food flavorings and compounds of related structure. II. Subacute and chronic toxicity. Food and Cosmetics Toxicology. 5:1967;141-157.
36. Haworth S., Lawlor T., Morteimans K., Speck W., Zeiger E. Salmonella mutagenicity test results for 250 chemicals. Environmental Mutagenesis. 5:(Suppl. 1):1983;3-142.
37. Hazleton L.W., Tusing T.W., Zeitlin B.R., Thiessen R., Jr, Murer H.K. Toxicity of coumarin. Journal of Pharmacology and Experimental Therapeutics. 118:1956;348-358.
38. Hsie A.W., Casciano D.A., Couch D.B., Krahn D.F., O'Neill J.P., Whitfield B.L. The use of Chinese hamster ovary cells to quantify specific locus mutation and to determine mutagenicity of chemicals. A report of the Gene-Tox Program. Mutation Research. 86:1981;193-214.
39. Huang M-T., Chang R.L., Fortner J.G., Conney A.H. Studies on the mechanism of activation of microsomal benzo[a]pyrene hydroxylation by flavonoids. Journal of Biological Chemistry. 256:1981;6829-6836.
40. Kokron O., Maca S., Gasser G., Schmidt P.R. Cimetidine and coumarin therapy of renal cell carcinoma; A pilot study. Oncology. 48:1991;102-106.
41. 1-adduct formation in rat and human small bowel enterocytes. Gastroenterology. 106:1994;433-439.
42. Lake B. G. (1984) Investigations into the mechanism of coumarin-induced hepatotoxicity in the rat. Archives of Toxicology (Supplement 7) 16-29.
43. 14C]coumarin to polar and covalently bound products by hepatic microsomes from the rat, Syrian hamster, gerbil and humans. Food and Chemical Toxicology. 30:1992;105-115.
44. Lake B.G., Grasso P. Comparison of the hepatotoxicity of coumarin in the rat, mouse, and Syrian hamster: a dose and time response study. Fundamental and Applied Toxicology. 34:1996;105-117.
45. Loprinzi C.L., Sloan J., Kugler J. Coumarin-induced hepatoxicity. Journal of Clinical Oncology. 15:1997;3167-3168.
46. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry. 193:1951;265-275.
47. Machanoff R., O'Neill J.P., Hsie A.W. Quantitative analysis of cytotoxicity and mutagenicity of benzo[a]pyrene in mammalian cells (CHO/HGPRT system). Chemico-Biological Interactions. 34:1981;1-10.
48. Marshall M.E., Butler K., Hermansen D. Treatment of hormone-refractory stage D carcinoma of prostate with coumarin (1,2-benzopyrone) and cimetidine: A pilot study. Prostate. 17:1990;95-99.
49. 1 in the rat and mouse. Toxicology and Applied Pharmacology. 90:1987;401-409.
50. Morris D.L., Ward J.J. B. Coumarin inhibits micronuclei formation induced by benzo(a)pyrene in male but not female ICR mice. Environmental and Molecular Mutagenesis. 19:1992;132-138.
51. 1 mice (gavage studies). # TR-422. U.S. Department of Health and Human Services, National Institutes of Health, Research Triangle Park, NC.
52. 1 by hamster liver CYP2A enzymes. Chemico-Biological Interactions. 93:1994;41-50.
53. 14C]coumarin by rat hepatic microsomes. Xenobiotica. 21:1991;499-514.
54. Pohl R.J., Fouts J.R. A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Analytical Biochemistry. 107:1980;150-155.
55. 1 carcinogenesis: Comparative kinetics of microsomal biotransformation. Cancer Research. 50:1990;615-620.
56. 1 by human liver microsomes: role of cytochrome P450 IIIA enzymes. Toxicology and Applied Pharmacology. 108:1991;436-447.
57. 1. Chemical Research in Toxicology. 5:1992;202-210.
58. Sanyal R., Darroudi F., Parzefall W., Nagao M., Knasmüller S. Inhibition of the genotoxic effects of heterocyclic amines in human derived hepatoma cells by dietary bioantimutagens. Mutagenesis. 12:1997;297-303.
59. Sasaki Y.F., Imanishi H., Ohta T., Shirasu Y. Effects of antimutagenic flavourings on SCEs induced by chemical mutagens in cultured Chinese hamster cells. Mutation Research. 189:1987;313-318.
60. Sasaki Y.F., Imanishi H., Wantanabe M., Ohta T., Shirasu Y. Suppressing effect of antimutagenic flavorings on chromosome aberrations induced by UV-light or X-rays in cultured Chinese hamster cells. Mutation Research. 229:1990;1-10.
61. Shilling W.H., Crampton R.F., Longland R.C. Metabolism of coumarin in man. Nature. 221:1969;664-665.
62. NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proceedings of the National Academy of Sciences of the U.S.A. 86:1989;462-465.
63. Sparnins V.L., Venegas P.L., Wattenberg L.W. Enhancement of glutathione S-transferase activity by compounds inhibiting chemical carcinogenesis and by dietary constituents. Journal of the National Cancer Institute. 68:1982;493-496.
64. Steel R. G. D. and Torrie J. H. (1960) Principles and Procedures of Statistics, pp. 106-107. McGraw-Hill, New York.
65. 1-DNA binding in rainbow trout by CYP1A inhibitors: α-naphthoflavone, β-naphthoflavone and trout CYP1A1 peptide antibody. Comparative Biochemistry and Physiology. 110C:1995;273-280.
66. Thompson L.H., Salazar E.P., Brookman K.W., Hoy C.A. Hypersensitivity to cell killing and mutation induction by chemical carcinogens in an excision repair-deficient mutant of CHO cells. Mutation Research. 112:1983;329-344.
67. Ueng Y.F., Kuwabara T., Chun Y-J., Guengerich F.P. Cooperativity in oxidations catalyzed by cytochrome P450 3A4. Biochemistry. 36:1997;370-381.
68. 1 by bacterial recombinant human cytochrome P450 enzymes. Chemical Research in Toxicology. 8:1995;218-225.
69. Wattenberg L.W., Lam L.K., Fladmoe A.V. Inhibition of chemical carcinogen-induced neoplasia by coumarins and α-angelicalactone. Cancer Research. 39:1979;1651-1654.
70. 1 hybrid. Journal of Biological Chemistry. 254:1979;5641-5646.
71. Yamano S., Tatsuno J., Gonzalez F.J. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry. 29:1990;1322-1329.
72. Yun C-H., Shimada T., Guengerich F.P. Purification and characterization of human liver microsomal cytochrome P-450 2A6. Molecular Pharmacology. 40:1991;679-685.